gamma-delta T cells have unique features in comparison to alpha-beta T cells. It has now become clear that gamma-delta T cells recognize non-peptide and non-processed bacterial and environmental antigens, as well as stress-associated antigens expressed on epithelial cells and on certain tumor lines and primary carcinomas. However, understanding of gamma-delta T cell biology, especially cytokine responses, has lagged far behind that of alpha-beta T cells. Preliminary studies from our lab have shown that while polarization of native gamma-delta T cells in vitro can yield cells that produce IFN-gamma or IL-4 (like alpha-beta T cells), gamma-delta T cells default to a Th1 pathway, predominantly producing IFN-gamma, even in the presence of IL-4. Moreover, IL-12 signaling in gamma-delta T cells is constitutive and dissociated from IL-4-mediated regulation. Based on these data, the hypothesis is raised that the molecular mechanisms for gamma-delta T cell differentiation, especially the factors that modulate gamma-delta T cell polarization, are different from those in alpha-beta CD4+ T cells, and that gamma-delta T cells play important roles in early intracellular pathogen protection and in tumor immunity through their predominant production of IFN-gamma. To address these hypotheses, the following specific aims will be carried out:
Aim l. To define the factors that regulate gamma-delta T cell IFN-gamma production in vitro.
Aim 2. To define the factors that modulate gamma-delta T cell IL-4 production in vitro.
Aim 3. To define in vivo the roles of gamma-delta T cells in regulating CD4+ T cell polarization.
Aim 4. To define the role of IFN-gamma produced by gamma-delta T cells in pathogen protection and in tumor immunity. Study of the mechanisms of gamma-delta T cell differentiation in vitro and their functions in vivo is critical for understanding the function of gamma-delta T cells in immune responses.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Scientist Development Award - Research & Training (K01)
Project #
5K01AR002188-05
Application #
6864890
Study Section
Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee (AMS)
Program Officer
Gretz, Elizabeth
Project Start
2001-03-26
Project End
2006-02-28
Budget Start
2005-03-01
Budget End
2006-02-28
Support Year
5
Fiscal Year
2005
Total Cost
$126,090
Indirect Cost
Name
Yale University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Lim, Jae Hyang; Stirling, Brigid; Derry, Jonathan et al. (2007) Tumor suppressor CYLD regulates acute lung injury in lethal Streptococcus pneumoniae infections. Immunity 27:349-60
Tao, Jian; Gao, Yunfei; Li, Ming O et al. (2007) JNK2 negatively regulates CD8+ T cell effector function and anti-tumor immune response. Eur J Immunol 37:818-29
Chen, Liang; He, Weifeng; Kim, Sean T et al. (2007) Epigenetic and transcriptional programs lead to default IFN-gamma production by gammadelta T cells. J Immunol 178:2730-6
You, Xin; Pan, Meng; Gao, Wenli et al. (2006) Effects of a novel tylophorine analog on collagen-induced arthritis through inhibition of the innate immune response. Arthritis Rheum 54:877-86
Gao, Yunfei; Zhang, Dongqing; Sun, Buxiang et al. (2006) Active hexose correlated compound enhances tumor surveillance through regulating both innate and adaptive immune responses. Cancer Immunol Immunother 55:1258-66
Gao, Yunfei; Tao, Jian; Li, Ming O et al. (2005) JNK1 is essential for CD8+ T cell-mediated tumor immune surveillance. J Immunol 175:5783-9
Pan, Meng; Kang, Insoo; Craft, Joe et al. (2004) Resistance to development of collagen-induced arthritis in C57BL/6 mice is due to a defect in secondary, but not in primary, immune response. J Clin Immunol 24:481-91
Gao, Yunfei; Yang, Wancai; Pan, Meng et al. (2003) Gamma delta T cells provide an early source of interferon gamma in tumor immunity. J Exp Med 198:433-42
Yin, Zhinan; Bahtiyar, Gul; Zhang, Na et al. (2002) IL-10 regulates murine lupus. J Immunol 169:2148-55